Final analysis of the MAGNOLIA trial: zanubrutinib in marginal zone lymphoma
Final analysis of the MAGNOLIA trial: zanubrutinib in
Clinical findings with sundry targets in various B-cell malignancies
Clinical findings with sundry targets in various B-cel
Follicular lymphoma: bispecific and PI3Kδ-targeted approaches
Follicular lymphoma: bispecific and PI3Kδ-targeted app
New approaches in relapsed and refractory DLBCL
New approaches in relapsed and refractory DLBCL Pol
Latest updates on BTKi-treatment in WM
Latest updates on BTKi-treatment in WM Long-term BT
Emergent BTKi treatments in WM
Emergent BTKi treatments in WM Additionally to ibrut
BTK inhibition in Waldenström’s macroglobulinemia: trial updates and biomarker analysis
BTK inhibition in Waldenström’s macroglobulinemia: tri
Management of WM patients previously exposed to BTK-inhibitors
Management of WM patients previously exposed to BTK-in
Further steps to improve efficacy and safety in acute myeloid leukemia
Further steps to improve efficacy and safety in acute
Active monotherapies and combinations in mantle cell lymphoma
Active monotherapies and combinations in mantle cell l
